Basal Medium Supplementation to Reduce Trisulfide Bonds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Trisulfide bonds in recombinantly produced therapeutic polypeptides introduce heterogeneity, making it challenging to ensure product quality and consistency due to their formation during manufacturing.
Innovation Solution
A method involving a basal medium with specific concentrations of iron, riboflavin, pyridoxine, folic acid, cyanocobalamin, hypotaurine, and methionine is used to culture host cells, which reduces trisulfide bond levels in polypeptides by supplementing with chelating and reducing agents before or after harvesting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If standard cell culture media are used for recombinant polypeptide production, then polypeptides are produced efficiently, but trisulfide bonds form causing product heterogeneity
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition of cell culture media through controlled supplementation with chelating agents (EDTA, DTPA, citrate) and reducing agents (cysteine, glutathione, TCEP) at specific concentrations. These parameter changes in media composition directly reduce trisulfide bond formation while maintaining polypeptide production efficiency, resolving the contradiction between productivity and manufacturing precision
Solution Approach 2:
The patent uses chelating agents and reducing agents as intermediary substances that mediate between the cell culture system and the polypeptide product. These intermediaries bind metal ions and maintain reducing conditions in the media, preventing trisulfide bond formation without directly interfering with polypeptide expression, thus maintaining productivity while improving product homogeneity
2Ease of manufacture
If trisulfide bond formation is not controlled, then manufacturing process is simple, but product quality and consistency deteriorate
Solution Approach 1:
The patent implements preliminary action by pre-supplementing cell culture media with chelating and reducing agents before initiating polypeptide production. This proactive measure establishes protective conditions that prevent trisulfide bond formation during the entire manufacturing process, ensuring product quality consistency without complicating the manufacturing workflow
Solution Approach 2:
The patent enables self-service by designing a media supplementation system that automatically maintains reducing conditions throughout the culture process. The chelating and reducing agents continuously scavenge metal ions and maintain low redox potential without requiring external intervention, allowing the system to self-regulate and prevent trisulfide bond formation while maintaining simple manufacturing operations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively decreases trisulfide bond levels in polypeptides, enhancing their quality and consistency by reducing heterogeneity and improving manufacturing processes.
Implementation Method 1
supplementing with chelating and reducing agents
Implementation Method 2
supplementing with chelating and reducing agents before or after harvesting
Data Source
AI summary
Provided herein are cell culture media and methods culturing host cells expressing polypeptides to reduce the level of trisulfide bonds in polypeptides produced by the host cells.


